Scientists who developed the first yeast model of Parkinson's disease (PD) have been able to describe the mechanisms of an important gene's role in the disease. Tiago Fleming Outeiro, Ph.D., and Susan Lindquist, Ph.D., of the Whitehead Institute for Biomedical Research in Cambridge, Massachusetts, studied the gene's actions under normal conditions and under abnormal conditions to learn how and when the gene's product, alpha-synuclein, becomes harmful to surrounding cells. The scientists created a yeast model that expresses the alpha-synuclein gene, which has been implicated in Parkinson's disease (PD). Yeast models are often used in the study of genetic diseases because they offer researchers a simple system that allows them to clarify how genes work.
The National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, funded the study, which appears in the December 5, 2003, issue of Science.
The alpha-synuclein protein, which is found broadly in the brain, has been implicated in several neurodegenerative disorders. Sometimes a mutation or a misfolding of the protein causes the problems; other times there are too many copies of the normal gene. A study earlier this year reported that patients with a rare familial form of PD had too many normal copies of the alpha-synuclein gene, which resulted in a buildup of protein inside brain cells, causing the symptoms of PD.
Drs. Outeiro and Lindquist conducted their study by creating one yeast that expresses wild type synuclein, using the normal gene, and another yeast that expresses two mutant forms, using a mutated version of the gene found in patients with PD.
One theory for the cause of PD is that an aging brain no longer has the capacity to cope with accumulating or misfolding proteins. A normal healthy brain has the ability to clear out excess or mutant proteins through a process known as the quality control system. In the yeast model of PD, when
'"/>
Contact: Margo Warren
warrenm@ninds.nih.gov
301-496-5751
NIH/National Institute of Neurological Disorders and Stroke
4-Dec-2003
Page: 1 2 Related biology news :1.
Yeast mutations offer window into human disease2.
Yeast helps researchers better understand Parkinsons mystery3.
Yeast, wormwood & bacterial genes combine in microbial factory to make antimalarial drug4.
Yeast genomes reveal new sites of gene control5.
Yeast research targets drug resistance battle6.
Yeast underscores complexity of genetic variation between people7.
Yeast Provides Evidence For Continuous Membrane Theory8.
Yeast Rises To A New Occasion9.
Bakers Yeast Causes Chemical Reactions And Sweet Smelling Labs10.
Poetically Timed With Spring, Budding Yeast Yield Possible Insight Into Male Fertility--And Infertility11.
Mutate Or Die: New Polymerase Gives Desperate Yeast An Option